Clinical Trial Update: Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.

View source ↗

Summary

This clinical trial update investigates pro-calcitonin as a biomarker for ischemia in patients with complicated coronary intervention; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Saint Michael's Medical Center | Conditions: Coronary Disease | Status: UNKNOWN